Pregnancy and Neonatal Outcomes Following Prenatal Exposure to Dolutegravir

Journal of Acquired Immune Deficiency Syndromes - United States
doi 10.1097/qai.0000000000002035
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)